LacPro Industries, LLC Named Techpoint Mira Award Finalist
Fort Wayne-based LacPro, a biotherapeutic company developing a product for Clostridium difficile Infection, has been named a finalist for Innovation of the Year.
Fort Wayne, IN, April 22, 2009 --(PR.com)-- Fort Wayne-based LacPro, a biotherapeutic company developing a product for Clostridium difficile Infection, has been named a finalist for Innovation of the Year.
Fort Wayne based LacPro Industries, LLC has been named a finalist for Innovation of the Year in the 2009 TechPoint Mira Awards. The Mira Awards highlight the accomplishments of Indiana's most innovative and successful technology-driven organizations. LacPro, a new probiotic-based biotherapeutic company, is developing a new biologic for the prevention and treatment of Clostridium difficile Infection (CDI).
“We are honored to be included in this group of talented companies and appreciate the recognition of our biologic therapeutic,” said Melinda Schriver, President of LacPro. The incidence of CDI is increasing rapidly and is further complicated by the emergence of a more virulent, drug resistant strain. It is estimated that there are between 250,000 – 500,000 cases of CDI in the U.S. each year, resulting in longer hospital stays and an estimated $1.1 billion in additional costs. Clostridium difficile Infection is a debilitating diarrhea that results from antibiotic use and may lead to Colitis, more serious instestinal conditions, sepsis, and even death.
The Centers for Disease Control has identified several major clinical problems regarding CDI, including the need for therapeutics that will prevent Clostridium difficile Infection and also treat severe disease. LacPro is on track to develop a therapeutic that can both prevent and treat the disease, without the use of current toxic antibiotic therapies, becoming one of the nation’s first probiotic biologic therapies.
The 2009 award winners will be announced at an “Oscars-style” award ceremony being held Sat., May 16 at The Westin Indianapolis.
About LacPro
LacPro is a Fort Wayne based biotherapeutic company dedicated to the development and commercialization of innovative probiotic medical foods and biotherapeutics with rigorously tested health benefits. Visit www.lacpro.com.
About TechPoint
TechPoint is Indiana’s only statewide technology initiative, representing industry stakeholders including publicly-traded companies, private businesses, colleges and research universities, and local economic development organizations. The mission of TechPoint is to accelerate Indiana’s emerging and vibrant information technology sector by: promoting the successes of IT companies and professionals; supporting the formation, expansion, and attraction of IT companies; and advocating appropriate public policy. Visit www.techpoint.org.
###
Contact:
Melinda Schriver
LacPro Industries, LLC
President
(260) 387-5552, mschriver@lacpro.com
www.lacpro.com
Fort Wayne based LacPro Industries, LLC has been named a finalist for Innovation of the Year in the 2009 TechPoint Mira Awards. The Mira Awards highlight the accomplishments of Indiana's most innovative and successful technology-driven organizations. LacPro, a new probiotic-based biotherapeutic company, is developing a new biologic for the prevention and treatment of Clostridium difficile Infection (CDI).
“We are honored to be included in this group of talented companies and appreciate the recognition of our biologic therapeutic,” said Melinda Schriver, President of LacPro. The incidence of CDI is increasing rapidly and is further complicated by the emergence of a more virulent, drug resistant strain. It is estimated that there are between 250,000 – 500,000 cases of CDI in the U.S. each year, resulting in longer hospital stays and an estimated $1.1 billion in additional costs. Clostridium difficile Infection is a debilitating diarrhea that results from antibiotic use and may lead to Colitis, more serious instestinal conditions, sepsis, and even death.
The Centers for Disease Control has identified several major clinical problems regarding CDI, including the need for therapeutics that will prevent Clostridium difficile Infection and also treat severe disease. LacPro is on track to develop a therapeutic that can both prevent and treat the disease, without the use of current toxic antibiotic therapies, becoming one of the nation’s first probiotic biologic therapies.
The 2009 award winners will be announced at an “Oscars-style” award ceremony being held Sat., May 16 at The Westin Indianapolis.
About LacPro
LacPro is a Fort Wayne based biotherapeutic company dedicated to the development and commercialization of innovative probiotic medical foods and biotherapeutics with rigorously tested health benefits. Visit www.lacpro.com.
About TechPoint
TechPoint is Indiana’s only statewide technology initiative, representing industry stakeholders including publicly-traded companies, private businesses, colleges and research universities, and local economic development organizations. The mission of TechPoint is to accelerate Indiana’s emerging and vibrant information technology sector by: promoting the successes of IT companies and professionals; supporting the formation, expansion, and attraction of IT companies; and advocating appropriate public policy. Visit www.techpoint.org.
###
Contact:
Melinda Schriver
LacPro Industries, LLC
President
(260) 387-5552, mschriver@lacpro.com
www.lacpro.com
Contact
LacPro Industries LLC
Gerald Vandeveer
260-387-5552
www.lacpro.com
260-445-3971
Gerald Vandeveer
260-387-5552
www.lacpro.com
260-445-3971
Contact
Categories